OPALGENIX Trademark

Trademark Overview

On Wednesday, November 11, 2020, a trademark application was filed for OPALGENIX with the United States Patent and Trademark Office. The USPTO has given the OPALGENIX trademark a serial number of 90312995. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by OpalGenix, Inc.. The OPALGENIX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic testing for medical purposes
opalgenix

General Information

Serial Number90312995
Word MarkOPALGENIX
Filing DateWednesday, November 11, 2020
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6981060
Registration DateTuesday, February 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements

Pseudo MarkOPAL GENIX
Goods and ServicesGenetic testing for medical purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 11, 2021
Primary Code044
First Use Anywhere DateTuesday, July 7, 2020
First Use In Commerce DateSunday, May 1, 2022

Trademark Owner History

Party NameOpalGenix, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCarmel, IN 46032
Party NameOpalGenix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarmel, IN 46032
Party NameOpalGenix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarmel, IN 46032

Trademark Events

Event DateEvent Description
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Friday, January 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 12, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, January 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 12, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, January 12, 2023SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, June 1, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, May 27, 2022USE AMENDMENT FILED
Friday, May 27, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, March 31, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022SOU EXTENSION 1 GRANTED
Thursday, January 20, 2022SOU EXTENSION 1 FILED
Tuesday, March 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 23, 2022NOTICE OF REVIVAL - E-MAILED
Wednesday, February 23, 2022EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, February 23, 2022PETITION TO REVIVE-GRANTED
Wednesday, February 23, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 20, 2021ASSIGNED TO EXAMINER
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 14, 2020NEW APPLICATION ENTERED

Related Keywords

opalgenix purposes medical testing genetic